Dr Reddys Laboratories annual depreciation and amortization
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories Depreciation & Amortization Growth & History (RDY)
Dr Reddys Laboratories's depreciation and amortization was $200.0M for fiscal 2025.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-03-31 | $200.0M | $22.0M | +12.36% |
| 2024 | 2024-03-31 | $178.0M | $24.0M | +15.58% |
| 2023 | 2023-03-31 | $154.0M | −$2.0M | −1.28% |
| 2022 | 2022-03-31 | $156.0M | −$19.0M | −10.86% |
| 2021 | 2021-03-31 | $175.0M | $10.0M | +6.06% |
| 2020 | 2020-03-31 | $165.0M | −$11.0M | −6.25% |
| 2019 | 2019-03-31 | $176.0M | −$4.0M | −2.22% |
| 2018 | 2018-03-31 | $180.0M | — | — |
Dr Reddys Laboratories depreciation and amortization trends
Over the last five fiscal years, Dr Reddys Laboratories's depreciation and amortization increased from $165.0M to $200.0M, a change of $35.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗